Sign In
Buy AWH
$0.0820
+0 (+0%)
At Close: Jul 30, 2025
Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations
08:00am, Friday, 10'th Jan 2025
Interim CFO John Kallassy to Depart January 10 AUSTIN, TX / ACCESSWIRE / January 10, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq:AWH), a bio-analytical based women's health c
Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO
08:45am, Monday, 16'th Dec 2024
CEO Nicole Sandford will step down for personal reasons and will remain as a consultant to ensure a seamless transition CEO Nicole Sandford will step down for personal reasons and will remain as a con
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award
08:00am, Tuesday, 03'rd Dec 2024
The Company received the first $2 million from the ARPA-H Sprint for Women's Health Award The Company received the first $2 million from the ARPA-H Sprint for Women's Health Award
Aspira (AWH) Reports Q3 Loss, Lags Revenue Estimates
06:46pm, Tuesday, 19'th Nov 2024
Aspira (AWH) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.48 per share a year ago.
Aspira Women's Health Inc. (AWH) Q3 2024 Earnings Call Transcript
12:30pm, Thursday, 14'th Nov 2024
Aspira Women's Health Inc. (NASDAQ:AWH ) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Nicole Sandford - Chief Executive Officer & Director Sandy Milligan - Presid
AWH ANNOUNCES Q3 2024 FINANCIAL RESULTS
07:00am, Tuesday, 12'th Nov 2024
Achieved $141.6 million Net Revenue in Q3 2024 Reported $25.1 million in Adjusted EBITDA Anticipates $30 million of Annual Savings Through Transformation Initiatives MORRISTOWN, N.J. , Nov. 12, 202
Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024
08:00am, Monday, 04'th Nov 2024
Management to Announce Earnings Results and hold a call at 8:30 am ET Management to Announce Earnings Results and hold a call at 8:30 am ET
Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024
08:00am, Friday, 25'th Oct 2024
Event to feature presentations from Dr. Kevin Elias, Dr. Richard Gersh, Dr. Sandra Milligan, and Dr. Todd Pappas on the Company's development pipeline Event to feature presentations from Dr. Kevin Eli
Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health
11:23am, Wednesday, 23'rd Oct 2024
Aspira aims to develop a multi-marker miRNA blood test to aid in the detection of endometriosis Aspira aims to develop a multi-marker miRNA blood test to aid in the detection of endometriosis
Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch®
04:05pm, Tuesday, 15'th Oct 2024
New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation (CLEP) approval allows for OvaWatch® to be marketed in New York State New York State Department of Health (NYSDOH) Clinical
AWH to Hold Third Quarter 2024 Earnings Conference Call on Tuesday November 12, 2024
07:00am, Tuesday, 15'th Oct 2024
NEW JERSEY , Oct. 15, 2024 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, today
AWH Stock Plummets as Financial Data Reflects Losses
03:53pm, Monday, 07'th Oct 2024
Annex Insurance (AWH, Financial) stock recently experienced a sharp decline, dropping 7.47% to $0.761 per share. The trading volume stood at 16,266 shares, with a turnover rate of 0.10% and a price fl
Aspira Womens Health (AWH) Shares Plunge Amid Financial Challenges
03:56pm, Friday, 04'th Oct 2024
Aspira Womens Health (AWH, Financial) experienced a significant stock price drop of 7.80%, reaching $0.775 per share. The trading volume stood at 14,064 shares with a turnover rate of 0.09% and a vola
Aspira Women's Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08:00am, Friday, 06'th Sep 2024
AUSTIN, Texas, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disea
Dorsata's Alliance on Adnexal Masses to Support Aspira Stock
12:20pm, Monday, 02'nd Sep 2024
AWH's partnership with Dorsata is set to help with the adnexal masses diagnosis and treatment.
